MedinCell SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MedinCell SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2804
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MedinCell SA (MedinCell) is a developer of therapeutic solutions for the healthcare market. The company develops and commercializes BEPO, a technology based on custom proprietary copolymers and a biocompatible solvent for long acting injectables. Its BEPO provides a controlled release of therapeutic molecules and can be used to improve the treatment for a variety of chronic diseases or short-term illnesses. MedinCell provides peptides and proteins delivery services. MedinCell offers products for various indications including schizophrenia, pain and inflammation, depression, anaesthesia, organ transplant, and others. The company works for profit and non-profit projects, and collaborates with partners including pharmas, physicians, biotech firms, academics and foundations. MedinCell is headquartered in Jacou, France.

MedinCell SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9
MedinCell SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MedinCell SA, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
MedinCell Raises Funds through Financing 11
Partnerships 12
MedinCell Enters into Agreement with Sandoz International 12
Corbion and MedinCell Form Joint Venture 13
MedinCell SA – Key Competitors 14
MedinCell SA – Key Employees 15
MedinCell SA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jul 06, 2017: Dr. Sabri Markabi Joins MedinCell’s Supervisory Board 17
Product News 18
12/07/2017: MedinCell receives grant to develop long-acting injectable contraceptive 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
MedinCell SA, Pharmaceuticals & Healthcare, Key Facts 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9
MedinCell SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MedinCell Raises Funds through Financing 11
MedinCell Enters into Agreement with Sandoz International 12
Corbion and MedinCell Form Joint Venture 13
MedinCell SA, Key Competitors 14
MedinCell SA, Key Employees 15
MedinCell SA, Other Locations 16
MedinCell SA, Subsidiaries 16

List of Figures
MedinCell SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MedinCell SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MedinCell SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MedinCell SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MedinCell SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sanquin Blood Supply Foundation:医療機器:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Median Technologies SA (ALMDT)-医療機器分野:企業M&A・提携分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company provides services such as imaging services for CT, companion and monitoring tests; managed services and investigator site network services. Median’s imaging servic …
  • Airasia Group Berhad
    Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Achem Technology Corporation:企業の戦略・SWOT・財務分析
    Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Strike Energy Ltd (STX):石油・ガス:M&Aディール及び事業提携情報
    Summary Strike Energy Ltd (Strike Energy) is an oil and gas exploration and development company that explores, produces, and develops shale oil and gas. The company provides properties such as Eagle Ford Shale, Permian Basin, Cooper Basin, gulf coast conventional, and others. It has exploration and …
  • Gentiva Health Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gentiva Health Services Inc (Gentiva), a subsidiary of Kindred Healthcare Inc is a provider of home health and hospice services. It offers various patient care services at the patient’s home or hospital. Its major services include expert nursing care; disease and pain management; medication …
  • China Banking Corporation:企業の戦略・SWOT・財務情報
    China Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary China Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Exelixis Inc (EXEL)-製薬・医療分野:企業M&A・提携分析
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (c …
  • Gebr. Heinemann SE & Co. KG:戦略・SWOT・企業財務分析
    Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sun Pharmaceutical Industries Ltd (SUNPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psych …
  • J. Knipper and Company Inc:企業の戦略的SWOT分析
    J. Knipper and Company Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Broadridge Financial Solutions Inc (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions Inc (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Breas Medical AB-医療機器分野:企業M&A・提携分析
    Summary Breas Medical AB (Breas), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co Ltd, is a medical device company that manufactures and markets medical devices for anesthesia and respiratory markets. The company offers isleep and vivo products. It offers products such as isleep, vivo 30, v …
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The Kraft Heinz Co:戦略・SWOT・企業財務分析
    The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report Summary The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Meezan Bank Ltd:企業の戦略・SWOT・財務情報
    Meezan Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Meezan Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Industrias Nucleares do Brasil SA:企業の戦略的SWOT分析
    Industrias Nucleares do Brasil SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Fomento de Construcciones y Contratas S.A.:戦略・SWOT・企業財務分析
    Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report Summary Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆